本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Maze Therapeutics

24.60
-0.2200-0.89%
盤後24.600.00000.00%19:30 EDT
成交量:105.22萬
成交額:2,607.00萬
市值:13.59億
市盈率:-9.77
高:25.99
開:25.14
低:24.36
收:24.82
52周最高:53.65
52周最低:22.01
股本:5,524.87萬
流通股本:3,725.03萬
量比:1.95
換手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-2.5172
每股收益(LYR):-3.0510
淨資產收益率:-37.35%
總資產收益率:-21.79%
市淨率:3.00
市盈率(LYR):-8.06

資料載入中...

2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/04/22

重要事件披露

Form 8-K - Current report
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/04

重要事件披露

Form 8-K - Current report
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933